Enhancing global access to cancer medicines von Cortes, Javier, Perez‐García, Jose Manuel, Llombart‐Cussac, Antonio, Curigliano, Giuseppe, El Saghir, Nagi S., Cardoso, Fatima, Barrios, Carlos H., Wagle, Shama, Roman, Javier, Harbeck, Nadia, Eniu, Alexandru, Kaufman, Peter A., Tabernero, Josep, García‐Estévez, Laura, Schmid, Peter, Arribas, Joaquín

Volltext

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy von Sledge, Jr, George W, Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A, Koh, Han, Grischke, Eva-Maria, Frenzel, Martin, Lin, Yong, Barriga, Susana, Smith, Ian C, Bourayou, Nawel, Llombart-Cussac, Antonio

Volltext

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies von Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad

Volltext

Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracyclin... von Kaufman, Peter A, Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A, Velikova, Galina, Olivo, Martin S, He, Yi, Dutcus, Corina E, Cortes, Javier

Volltext

Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging von Tromberg, Bruce J, Zhang, Zheng, Leproux, Anaïs, O'Sullivan, Thomas D, Cerussi, Albert E, Carpenter, Philip M, Mehta, Rita S, Roblyer, Darren, Yang, Wei, Paulsen, Keith D, Pogue, Brian W, Jiang, Shudong, Kaufman, Peter A, Yodh, Arjun G, Chung, So Hyun, Schnall, Mitchell, Snyder, Bradley S, Hylton, Nola, Boas, David A, Carp, Stefan A, Isakoff, Steven J, Mankoff, David

Volltext

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831... von PEREZ, Edith A, ROMOND, Edward H, SUMAN, Vera J, JEONG, Jong-Hyeon, DAVIDSON, Nancy E, GEYER, Charles E, MARTINO, Silvana, MAMOUNAS, Eleftherios P, KAUFMAN, Peter A, WOLMARK, Norman

Volltext

Fast 3-D Tomographic Microwave Imaging for Breast Cancer Detection von Grzegorczyk, T. M., Meaney, P. M., Kaufman, P. A., di Florio-Alexander, Roberta M., Paulsen, K. D.

Volltext

Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve von AHLES, Tim A, SAYKIN, Andrew J, MCDONALD, Brenna C, YUELIN LI, FURSTENBERG, Charlotte T, HANSCOM, Brett S, MULROONEY, Tamsin J, SCHWARTZ, Gary N, KAUFMAN, Peter A

Volltext

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study von Tolaney, Sara M., Kalinsky, Kevin, Kaklamani, Virginia G., D'Adamo, David R., Aktan, Gursel, Tsai, Michaela L., O'Regan, Ruth M., Kaufman, Peter A., Wilks, Sharon T., Andreopoulou, Eleni, Patt, Debra A., Yuan, Yuan, Wang, Grace, Savulsky, Claudio, Xing, Dongyuan, Kleynerman, Ella, Karantza, Vassiliki, Diab, Sami

Volltext

Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 tri... von Robertson, John FR, Prof, Ferrero, Jean-Marc, Prof, Bourgeois, Hugues, MD, Kennecke, Hagen, MD, de Boer, Richard H, FRACP, Jacot, William, MD, McGreivy, Jesse, MD, Suzuki, Samuel, MS, Zhu, Min, PhD, McCaffery, Ian, PhD, Loh, Elwyn, MD, Gansert, Jennifer L, MD, Kaufman, Peter A, MD

Volltext

The Role of Relational Information Processes and Technology Use in Customer Relationship Management von Jayachandran, Satish, Sharma, Subhash, Kaufman, Peter, Raman, Pushkala

Volltext

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer von Perez, Edith A, Suman, Vera J, Davidson, Nancy E, Gralow, Julie R, Kaufman, Peter A, Visscher, Daniel W, Chen, Beiyun, Ingle, James N, Dakhil, Shaker R, Zujewski, Joanne, Moreno-Aspitia, Alvaro, Pisansky, Thomas M, Jenkins, Robert B

Volltext

Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience von Meaney, Paul M, Kaufman, Peter A, Muffly, Lori S, Click, Michael, Poplack, Stephen P, Wells, Wendy A, Schwartz, Gary N, di Florio-Alexander, Roberta M, Tosteson, Tor D, Li, Zhongze, Geimer, Shireen D, Fanning, Margaret W, Zhou, Tian, Epstein, Neil R, Paulsen, Keith D

Volltext

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from t... von Neven, Patrick, Rugo, Hope S., Tolaney, Sara M., Iwata, Hiroji, Toi, Masakazu, Goetz, Matthew P., Kaufman, Peter A., Lu, Yi, Haddad, Nadine, Hurt, Karla C., Sledge, George W.

Volltext

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial von Pernas, Sonia, Martin, Miguel, Kaufman, Peter A, Gil-Martin, Marta, Gomez Pardo, Patricia, Lopez-Tarruella, Sara, Manso, Luis, Ciruelos, Eva, Perez-Fidalgo, Jose Alejandro, Hernando, Cristina, Ademuyiwa, Foluso O, Weilbaecher, Katherine, Mayer, Ingrid, Pluard, Timothy J, Martinez Garcia, Maria, Vahdat, Linda, Perez-Garcia, Jose, Wach, Achim, Barker, Debra, Fung, Samson, Romagnoli, Barbara, Cortes, Javier

Volltext

Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer von Goyal, Ravi K., Zhang, Jingchuan, Davis, Keith L., Sluga-O’Callaghan, Martina, Kaufman, Peter A.

Volltext

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Gro... von Connolly, Roisin M., Zhao, Fengmin, Miller, Kathy D., Lee, Min-Jung, Piekarz, Richard L., Smith, Karen L., Brown-Glaberman, Ursa A., Winn, Jennifer S., Faller, Bryan A., Onitilo, Adedayo A., Burkard, Mark E., Budd, George T., Levine, Ellis G., Royce, Melanie E., Kaufman, Peter A., Thomas, Alexandra, Trepel, Jane B., Wolff, Antonio C., Sparano, Joseph A.

Volltext

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine von Kazmi, Shayma, Chatterjee, Debanjana, Raju, Dheeraj, Hauser, Rob, Kaufman, Peter A.

Volltext

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal... von Tolaney, Sara M, Chan, Arlene, Petrakova, Katarina, Delaloge, Suzette, Campone, Mario, Iwata, Hiroji, Peddi, Parvin F, Kaufman, Peter A, De Kermadec, Elisabeth, Liu, Qianying, Cohen, Patrick, Paux, Gautier, Wang, Lei, Ternès, Nils, Boitier, Eric, Im, Seock-Ah

Volltext

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs von Hurvitz, Sara A, O'Shaughnessy, Joyce, Mason, Ginny, Yardley, Denise A, Jahanzeb, Mohammad, Brufsky, Adam, Rugo, Hope S, Swain, Sandra M, Kaufman, Peter A, Tripathy, Debu, Chu, Laura, Li, Haocheng, Antao, Vincent, Cobleigh, Melody

Volltext